Abbott इंडिया शेअर किंमत

Pharmaceuticals company Abbott India announced Q4FY26 & FY26 results Q4FY26 Financial Highlights: Revenue from Operations: Stood at Rs 1,709.51 crore in Q4FY26, registering a YoY increase of 6.54% compared to Rs 1,604.59 crore in Q4FY25, and a QoQ slight decline of 0.84% from Rs 1,724.04 crore in Q3FY26. Total Income: Reported at Rs 1,785.10 crore in Q4FY26, showing a YoY growth of 6.22% from Rs 1,680.61 crore in Q4FY25, and a QoQ decrease of 0.48% from Rs 1,793.80 crore in Q3FY26. Profit Before Tax (PBT): Reached Rs 531.23 crore in Q4FY26, reflecting a YoY growth of 10.05% against Rs 482.71 crore in Q4FY25, and a QoQ increase of 4.37% compared to Rs 508.98 crore in Q3FY26. Profit for the Period (PAT): Achieved Rs 394.93 crore in Q4FY26, up by 7.60% YoY from Rs 367.04 crore in Q4FY25, and growing 5.05% QoQ from Rs 375.96 crore in Q3FY26. Total Comprehensive Income: Stood at Rs 396.66 crore in Q4FY26, up from Rs 361.60 crore in Q4FY25 and Rs 373.31 crore in Q3FY26. Earnings Per Share (EPS): Basic and Diluted EPS for Q4FY26 was Rs 185.85, an increase from Rs 172.72 in Q4FY25 and Rs 176.92 in Q3FY26. FY26 Financial Highlights: Revenue from Operations: Increased to Rs 6,929.05 crore in FY26, marking a YoY growth of 8.11% from Rs 6,409.15 crore in FY25. Total Income: Jumped to Rs 7,217.19 crore in FY26, representing a YoY growth of 7.96% compared to Rs 6,684.73 crore in FY25. Profit Before Tax (PBT): Grew to Rs 2,079.27 crore in FY26, up by 10.19% YoY from Rs 1,886.95 crore in FY25. Profit for the Year (PAT): Reported at Rs 1,552.02 crore in FY26, indicating a YoY increase of 9.73% against Rs 1,414.44 crore in FY25. Total Comprehensive Income: Achieved Rs 1,551.17 crore in FY26, growing from Rs 1,409.02 crore in FY25. Earnings Per Share (EPS): Basic and Diluted EPS for the full year FY26 was Rs 730.36, compared to Rs 665.62 in FY25. Dividend: The Board of Directors recommended a final dividend of Rs 525 and a special dividend of Rs 131 per equity share of Rs 10 each for FY26. Result PDF

• ट्रेंडलाईन
• 3 आठवडे 1 दिवसापूर्वी

फार्मास्युटिकल्स कंपनी ॲबॉट इंडियाने Q3FY26 परिणाम महसूल जाहीर केला: Q3FY25 दरम्यान ₹1,614.28 कोटी सापेक्ष ₹1,724.04 कोटी, बदल 7%. पीबीटी: Q3FY25 दरम्यान ₹ 487.59 कोटी सापेक्ष ₹ 508.98 कोटी, बदल 4%. पीएटी: Q3FY25 दरम्यान ₹ 360.78 कोटी सापेक्ष ₹ 375.96 कोटी, बदल 4%. ईपीएस: Q3FY26 साठी रु. 176.92. रिझल्ट PDF

• ट्रेंडलाईन
• 3 महिने 2 आठवड्यांपूर्वी

फार्मास्युटिकल कंपनीचा स्टॉक दिवसादरम्यान 3.86 टक्के वाढून 31,500 प्रति शेअर झाला

• बिझनेस स्टँडर्ड
• 1 वर्षापूर्वी